HGS FIELD definition

HGS FIELD means human and animal health care, excluding GENE THERAPY, and subject to Paragraph 2.4(c), excluding GENE THERAPY VACCINES.
Sample 1Sample 2
HGS FIELD means: (i) Gene Therapy including Gene Therapy Vaccines, (ii) Antisense and (iii) biotransformation of a chemical to prepare pharmaceutically active agents for human or animal use, or intermediates therefor, which active agents or intermediates therefore were discovered prior to May 19, 1993. 1.20 "HGS Patents" shall mean all patents and patent applications to the extent that they claim HGS Technology, which are or become owned by HGS or to which HGS otherwise has, now or in the future, the right to grant licenses, or sublicenses. Included within the definition of HGS Patents are all continuations, continuations-in-part, divisions, patents of addition, reissues, renewals or extensions thereof and all supplementary-like patent certificates. HGS Patents shall include HGS' interest in patents and patent applications to which HGS is a joint owner pursuant to Paragraph 14.1. 1.21 "HGS Technology" shall mean the following technology, whether patented, patentable or not: (a) sxxxxxxx xxxx with respect to human DNA and expression products thereof and Bioinformatics relating thereto, in each case developed by or for HGS prior to and through the end of the Initial Research Term, (b) information on biological function of Therapeutic Proteins developed by HGS prior to the Initial Research Term, (c) HGS clones containing sequences in (a), (d) information on
Sample 1Sample 2
HGS FIELD means (i) ANTISENSE and (ii) biotransformation of a chemical to prepare pharmaceutically active agents for human or animal use, or intermediates therefor, which active agents were DISCOVERED before the EFFECTIVE DATE, and (iii)
Sample 1

More Definitions of HGS FIELD

HGS FIELD means: (i) GENE THERAPY, GENE THERAPY VACCINES (other than GENE THERAPY VACCINES as to which SB obtains rights under Section 7), (ii) ANTISENSE, (iii) biotransformation of a chemical to prepare pharmaceutically active agents for human or animal use, or intermediates therefor, which active agents or intermediates were discovered before May 19, 1993. 1.28."HGS PATENT(S)" shall mean all patents and patent applications to the extent they claim HGS TECHNOLOGY, which are or become owned by HGS or to which HGS otherwise has, now or in the future, the right to grant licenses. Included within the definition of HGS PATENTS are all continuations, continuations-in-part, divisions, patents of addition, reissues, renewals, extensions, registrations, confirmations, re-examinations thereof and any provisional applications and all SPCs. 1.29."HGS PRODUCT" shall mean (1) a COLLABORATION PRODUCT in the HGS FIELD; or (2) a COLLABORATION PRODUCT in the SB FIELD (a) to which HGS obtains rights in accordance with Section 6; and/or (b) which is a THERAPEUTIC PROTEIN discovered or developed by or on behalf of HGS after the INITIAL RESEARCH TERM; and/or (c) which is a DRUG PRODUCT or ANTIBODY PRODUCT discovered or developed by or on behalf of HGS at any time. 1.30."HGS TECHNOLOGY" shall mean any and all data, substances, processes, materials, formulae, know-how and inventions with respect to GENES and/or expression products thereof (including sequence and function) which are useful within the HGS FIELD or the SB FIELD and which are developed by or on behalf of HGS during or prior to the INITIAL RESEARCH TERM and which are owned by HGS or with respect to which HGS has a right to grant a license. In the event HGS in-licenses from a THIRD PARTY a DRUG PRODUCT, ANTIBODY PRODUCT or THERAPEUTIC PROTEIN in each case discovered by a THIRD PARTY with no use of HGS TECHNOLOGY, such product and information generated by HGS directly related to the research and development of such product, shall not be HGS TECHNOLOGY. 1.31."HGS SPECIAL TECHNOLOGY shall mean (1) all HGS TECHNOLOGY in existence prior to the EFFECTIVE DATE and required to be transferred or transferred to SB under the COLLABORATION AGREEMENT and (2) all HGS TECHNOLOGY developed by or for HGS after the EFFECTIVE DATE and during the INITIAL RESEARCH TERM required to be transferred or transferred to SB by HGS which is: (a) xxxxxxxx xxxx with respect to cDNA and
Sample 1
HGS FIELD means: (i) Gene Therapy, (ii) Antisense and (iii) biotransformation of a chemical to prepare pharmaceutically active agents for human or animal use, or intermediates therefor, which active agents or intermediates therefor were discovered prior to May 19, 1993. 1.21 "HGS Technology" shall mean the following technology, whether patented, patentable or not: (a) xxxxxxxx xxxx with respect to Genes and expression products thereof and Bioinformatics relating thereto, in each case developed by or for HGS prior to and through the end of the Initial Research Term, (b) information on biological function of Therapeutic Proteins developed by HGS prior to the Initial Research Term, (c) HGS clones containing sequences in (a), (d) information on biological function of Targets developed by or for HGS prior to and through the end of the Initial Research Term, and (e) biological information on Therapeutic Proteins for use as Targets developed by HGS during the Initial Research Term and after such Therapeutic Protein has been claimed pursuant to Section 8. Bioinformatics in subparagraph (a) shall not include Bioinformatics licensed by HGS from a Third Party except where HGS has the royalty-free right to license such Bioinformatics to Synthelabo or where HGS has a royalty-bearing right to license such Bioinformatics to Synthelabo and Synthelabo agrees to pay all applicable royalties for its use of such license. 1.22 "HGS Patents" shall mean (i) all patents and patent applications to the extent that they claim HGS Technology and (ii) Blocking Claims of patents and patent applications filed prior to the end of the Initial Research Term, in each case, which are or become owned by HGS or to which HGS otherwise has, now or in the future, the right to grant licenses, or sublicenses. Included within the definition of HGS Patents are all continuations, continuations-in-part, divisions, patents of addition, reissues, renewals or extensions thereof and all SPCs. HGS Patents shall
Sample 1

Related to HGS FIELD

  • Licensed Field means all fields of use.

  • Licensed Field of Use means all fields.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Field of Use means all fields of use.

  • Exclusive Field means the diagnosis, treatment or prevention of any cancer in humans through the use of Engineered T-Cells, which shall exclude the diagnosis, treatment or prevention of medullary cystic kidney disease 1 regardless of whether such disease is characterized as a cancer.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Licensed Territory means worldwide.

  • Hemp products means all products made from industrial hemp,

  • Competing Product means [***].

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Fields of Use means UltraTemp, Ceris or Ceros technology for the transportation or appliance gas ignition markets.

  • New Products means any product which is not an Enhanced Product or Existing Product but which is substantially similar to an of this Agreement, "New Product" or "New Products" shall mean any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Commercialize or “Commercialization” means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Commercialized shall have corresponding meanings.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.